title: Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 coactivator recruitment by activation function 2.
abstract: The androgen receptor undergoes an androgen-specific NH(2)- and COOH-terminal interaction between NH(2)-terminal motif FXXLF and activation function 2 in the ligand binding domain. We demonstrated previously that activation function 2 forms overlapping binding sites for the androgen receptor FXXLF motif and the LXXLL motifs of p160 coactivators. Here we investigate the influence of the NH(2)- and COOH-terminal interaction on androgen receptor function. Specificity and relative potency of the motif interactions were evaluated by ligand dissociation rate and the stability of chimeras of transcriptional intermediary factor 2 with full-length and truncated androgen or glucocorticoid receptor. The results indicate that the androgen receptor activation function 2 interacts specifically and with greater avidity with the single FXXLF motif than with the LXXLL motif region of p160 coactivators, whereas this region of the glucocorticoid receptor interacts preferentially with the LXXLL motifs. Expression of the LXXLL motifs as a fusion protein with the glucocorticoid receptor resulted in loss of agonist-induced receptor destabilization and increased half-time of ligand dissociation. The NH(2)- and COOH-terminal interaction inhibited binding and activation by transcriptional intermediary factor 2. We conclude that the androgen receptor NH(2)- and COOH-terminal interaction reduces the dissociation rate of bound androgen, stabilizes the receptor, and inhibits p160 coactivator recruitment by activation function 2.
authors.affiliation: Department of Biochemistry, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
authors.forename: B
authors.initials: B
authors.lastname: He
authors.forename: N T
authors.initials: NT
authors.lastname: Bowen
authors.forename: J T
authors.initials: JT
authors.lastname: Minges
authors.forename: E M
authors.initials: EM
authors.lastname: Wilson
mesh_terms: D020816:Amino Acid Motifs; D000728:Androgens / Q000494:pharmacology*; D000818:Animals; D002352:Carrier Proteins / Q000737:chemistry / Q000378:metabolism*; D002460:Cell Line; D004268:DNA-Binding Proteins; D006801:Humans; D009687:Nuclear Proteins / Q000737:chemistry / Q000378:metabolism*; D051958:Nuclear Receptor Coactivator 2; D029543:Nucleocytoplasmic Transport Proteins; D016601:RNA-Binding Proteins; D011944:Receptors, Androgen / Q000737:chemistry* / Q000502:physiology; D011965:Receptors, Glucocorticoid / Q000737:chemistry / Q000502:physiology; D014157:Transcription Factors / Q000502:physiology; D015533:Transcriptional Activation
chemical_list: D000728:Androgens; D002352:Carrier Proteins; D004268:DNA-Binding Proteins; C491719:MYBBP1A protein, human; C498001:NCOA2 protein, human; D009687:Nuclear Proteins; D051958:Nuclear Receptor Coactivator 2; D029543:Nucleocytoplasmic Transport Proteins; D016601:RNA-Binding Proteins; D011944:Receptors, Androgen; D011965:Receptors, Glucocorticoid; D014157:Transcription Factors